New Oral Anticoagulants vs. Vitamin K Antagonists Among Patients With Cardiac Amyloidosis: Prognostic Impact

Background: Atrial arrhythmia (AA) is common among patients with cardiac amyloidosis (CA), who have an increased risk of intracardiac thrombus. The aim of this study was to explore the prognostic impact of vitamin K-antagonists (VKA) and direct oral anticoagulants (DOAC) in patients with CA. Methods...

Descripción completa

Detalles Bibliográficos
Autores principales: Cariou, Eve, Sanchis, Kevin, Rguez, Khailène, Blanchard, Virginie, Cazalbou, Stephanie, Fournier, Pauline, Huart, Antoine, Roussel, Murielle, Cintas, Pascal, Galinier, Michel, Carrié, Didier, Maury, Philippe, Lavie-Badie, Yoan, Lairez, Olivier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670403/
https://www.ncbi.nlm.nih.gov/pubmed/34917658
http://dx.doi.org/10.3389/fcvm.2021.742428

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670403/
https://www.ncbi.nlm.nih.gov/pubmed/34917658
http://dx.doi.org/10.3389/fcvm.2021.742428

Ejemplares similares